AASLD - Hepatitis Conference - Liver Conference - HCV - HepC - HBV - HepB

A Smart + Strong Site
Subscribe to:
Hepatitis E-newsletter
Join Us:
HIGHLIGHTS
What you need to know
> Blogs > Hep Exclusives > Hepatitis News > Lessons


Interferon-Free Hep C Treatment Safe & Effective

Combo with a next-wave protease inhibitor and a non-nucleoside polymerase inhibitor does well in phase IIb.



94% Hep C Cure Rate in Hard-to-Treat Patients

Triple combination therapy shows promise in phase II study.



Hep C Therapy Shows 100% Cure Rate

Positive news from interim data of an ongoing phase II study.


Safe and Effective for
Hep B

New study shows drug is safe and effective for long-term treatment of hep B.



New Therapy for Previous Non-Responders

Combination proved both safe and effective among patients with previous treatment experience.



Interferon-Free Hep C Regimen Has Over 90% Cure Rate

Three-drug regimen reached a 97% cure rate for treatment-naive patients.


Big Changes on Horizon for Hep C Treatment

Pharmaceutical industry is poised to revolutionize care over the coming years.



Incivek Safe for Coinfection

The hepatitis C drug is effective for people with both HIV and HCV.



New Combo Boasts High Hep C Cure Rates Across Genotypes

Therapy unlikely to enter phase III because they are manufactured by different companies.

NEWSFEED
AASLD Coverage
 
Baby Boomers With Hepatitis C Drive Demand for Liver Transplants

Abbott Announces Phase III Trials of Its Potent Hep C Direct Acting Agents

Long-term Entecavir Is Safe and Effective for Hep B Patients, Even with Cirrhosis

Daclatasvir, Asunaprevir Regimens Boast High Cure Rates in Hard-to-Treat Hep C

Interferon-Free Hep C Treatment With Faldaprevir is Safe & Effective

Liver Cancer Spikes Among Spanish Coinfected With HIV, Hepatitis

Tenofovir Is Safe and Effective for Hep B, Yields Little Bone Loss

Simeprevir Is Safe and Effective for Hep C Patients With Advanced Fibrosis

Daclatasvir, Sofosbuvir Combo Boasts High Hep C Cure Rates Across Genotypes

New Hep C Combo Therapies Safe & Effective for Previous Non-Responders

BMS’s Hep C Therapy Shows 94% Cure Rate in Hard-to-Treat Patients

Hep C Protease Inhibitor Incivek Is Safe, Effective for HIV Coinfection

Gilead’s Hep C Combo Therapy Shows 100% Cure Rate in Small Study

Abbott’s Interferon-Free Hep C Regimen Boasts Over 90% Cure Rates

 
HEP TV
Footage from the front lines
Professor Mark Sulkowski discusses the upcoming developments in the treatment of HCV.
> More Hep TV
TALK TO US
Tell us what you think
Poll
Are you do anything special this month to recognize that May is National Hepatitis Awareness Month?
Yes
No


Survey
USA Today/Hepatitis C Awareness Survey

Hepatitis C Reader Survey
© 2013 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.